The impact of baseline left ventricular size and mitral regurgitation on reverse left ventricular remodelling in response to carvedilol: size doesn't matter. [electronic resource]
- Heart (British Cardiac Society) Jul 2004
- 800-1 p. digital
Publication Type: Letter
1468-201X
10.1136/hrt.2002.009696 doi
Adrenergic beta-Antagonists--therapeutic use Carbazoles--therapeutic use Cardiomyopathy, Dilated--drug therapy Carvedilol Chronic Disease Echocardiography Humans Mitral Valve Insufficiency--diagnostic imaging Propanolamines--therapeutic use Retrospective Studies Ventricular Dysfunction, Left--complications Ventricular Remodeling--drug effects